3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives

Details 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives

C - Chemistry, Metallurgy

07

D

C07D 401/04 (2006.01) A61K 31/4545 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2680120

The present invention relates to novel compounds, in particular novel pyridinone derivatives according to Formula (I) including any stereochemically isomeric form thereof, or a pharmaceutically acceptable salt thereof or a solvate thereof, wherein all radicals are defined in the application and claims. The compounds according to the invention are positive allosteric modulators of metabotropic glutamate receptors subtype 2 (" mGluR2") which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. In particular, such diseases are centralnervous system disorders selected from the group of anxiety,schizophrenia, migraine, depression, and epilepsy. The invention is also directed to pharmaceutical compositions and processes to prepare such compounds and such compositions, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR2 is involved.

La présente invention porte sur de nouveaux composés, en particulier sur de nouveaux dérivés de pyridinone selon la Formule (I) comprenant toute forme de stéréochimiquement isomère de ceux-ci, ou sur un sel pharmaceutiquement acceptable de ceux-ci ou un solvate de ceux-ci, où tous les radicaux sont définis dans la description et les revendications. Les composés de l'invention sont des modulateurs allostériques positifs des récepteurs métabotropiques du glutamate sous-type 2 (<= mGluR2 >=) utiles dans le traitement ou la prévention de troubles neurologiques et psychiatriques associés au dysfonctionnement du glutamate et de maladies dans lesquelles le sous-type mGluR2 des récepteurs métabotropiques est mis en jeu, en particulier, des maladies comme des troubles du système nerveux central, dont l'anxiété, la schizophrénie, la migraine, la dépression et l'épilepsie. L'invention porte également sur des compositions pharmaceutiques et des procédés pour préparer de tels composés et de telles compositions, ainsi que sur l'utilisation de ces composés pour la prévention et le traitement de maladies dans lesquelles mGluR2 est mis en jeu.

Affiliated with

Also associated with

Rating

3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1772140